Skip to content

LA JOLLA PHARMACEUTICAL CO

Delisted

CIK 920465fmd_07HG64Z3B7BKRR36FT6PJJHBXRManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2010 to Jun 30, 2022, 49 periods

Latest annual · FY2021

Millions
Total revenues
76
Gross profit
26
Operating income
22
Net income
20
Free cash flow
28

Latest quarter · Q2 FY2022

Millions
Total revenues
11
Operating income
(1)
Net income
2
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
+95.7%
Revenue, 5 yearsFY2016 to FY2021
+161.8%
Net income, 5 yearsFY2016 to FY2021
n/m

LA JOLLA PHARMACEUTICAL CO financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$75.7 million$33.4 million+126.6%10-K 2022-03-09 · proof
Operating income$21.8 million-$35.8 million10-K 2022-03-09 · proof
Net income$19.7 million-$39.4 million10-K 2022-03-09 · proof
Cash from operating activities$28.2 million-$37.6 million10-K 2022-03-09 · proof
Free cash flow$28.2 million10-K 2022-03-09 · proof
Total assets$101.2 million$72.2 million+40.1%10-K 2022-03-09 · proof
Total liabilities$168 million$160.3 million+4.8%10-K 2022-03-09 · proof
Cash and cash equivalents$46.7 million$21.2 million+119.9%10-K 2022-03-09 · proof
What was LA JOLLA PHARMACEUTICAL CO's revenue in fiscal 2021?
LA JOLLA PHARMACEUTICAL CO reported revenue of $75.7 million for fiscal 2021 (the year ended Dec 31, 2021), against $33.4 million the year before (+126.6%). Source: the 10-K filed with the SEC on Mar 9, 2022. SEC
What was LA JOLLA PHARMACEUTICAL CO's operating income in fiscal 2021?
LA JOLLA PHARMACEUTICAL CO reported operating income of $21.8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$35.8 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2022. SEC
What was LA JOLLA PHARMACEUTICAL CO's net income in fiscal 2021?
LA JOLLA PHARMACEUTICAL CO reported net income of $19.7 million for fiscal 2021 (the year ended Dec 31, 2021), against -$39.4 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2022. SEC
What was LA JOLLA PHARMACEUTICAL CO's cash from operating activities in fiscal 2021?
LA JOLLA PHARMACEUTICAL CO reported cash from operating activities of $28.2 million for fiscal 2021 (the year ended Dec 31, 2021), against -$37.6 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2022. SEC
What was LA JOLLA PHARMACEUTICAL CO's free cash flow in fiscal 2021?
LA JOLLA PHARMACEUTICAL CO reported free cash flow of $28.2 million for fiscal 2021 (the year ended Dec 31, 2021). Source: the 10-K filed with the SEC on Mar 9, 2022. SEC
What are LA JOLLA PHARMACEUTICAL CO's total assets?
As of Dec 31, 2021, LA JOLLA PHARMACEUTICAL CO reported total assets of $101.2 million, against $72.2 million a year earlier (+40.1%). Source: the 10-K filed with the SEC on Mar 9, 2022. SEC
What are LA JOLLA PHARMACEUTICAL CO's total liabilities?
As of Dec 31, 2021, LA JOLLA PHARMACEUTICAL CO reported total liabilities of $168 million, against $160.3 million a year earlier (+4.8%). Source: the 10-K filed with the SEC on Mar 9, 2022. SEC
What are LA JOLLA PHARMACEUTICAL CO's cash and cash equivalents?
As of Dec 31, 2021, LA JOLLA PHARMACEUTICAL CO reported cash and cash equivalents of $46.7 million, against $21.2 million a year earlier (+119.9%). Source: the 10-K filed with the SEC on Mar 9, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:920465&period_type=annual&limit=5"

Information only, not investment advice.